Skip to content
Wenlo
Sign in

News

Market news

Press releases, earnings reports, SEC filings and insider trades from US large-cap companies, and PR Newswire releases from US-listed companies, newest first, with short AI summaries.

  • 10-QGEHCGE HealthCare Technologies Inc.

    Quarterly report

    GE HealthCare Technologies Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026. Total revenues for the third quarter were $5,513 million, representing a 7.2% increase compared to the same period in 2025. Net income attributable to GE HealthCare for the quarter was $615 million.

    Source: SEC EDGAR

  • Press releaseGEHCGE HealthCare Technologies Inc.

    GE HealthCare reports third quarter 2026 financial results

    GE HealthCare Technologies Inc. announced its third quarter 2026 financial results, reporting revenues of $5.5 billion and net income attributable to GE HealthCare of $615 million. The company also raised its full-year 2026 guidance, driven by strong top-line growth and margin expansion. Additionally, GE HealthCare announced that Jeannette Bankes will resign as President and CEO of Patient Care Solutions, with Neal Sandy succeeding her starting November 16, 2026.

    Source: SEC EDGAR

  • 10-QBIIBBiogen Inc.

    Quarterly report

    Biogen Inc. filed its quarterly report for the period ended September 30, 2026. The filing provides a comprehensive discussion of financial condition, market risks, legal proceedings, and internal controls. No share repurchases were made during the third quarter of 2026.

    Source: SEC EDGAR

  • 10-QGEVGE Vernova Inc.

    Quarterly report

    GE Vernova Inc. filed its quarterly report for the period ended September 30, 2026, reporting total revenues of $12.6 billion and net income of $1.3 billion for the third quarter. Diluted earnings per share were $4.81, while free cash flow reached $15.3 billion for the first nine months of the year. Additionally, the company announced an increase in its share repurchase authorization to $20.0 billion.

    Source: SEC EDGAR

  • Press releaseTELTE Connectivity plc

    TE Connectivity delivers 12% sales increase and over 20% EPS growth in fiscal fourth quarter

    TE Connectivity plc announced its fourth quarter and full year fiscal 2026 results, reporting record net sales of $5.3 billion for the quarter—a 12% increase year over year—and full year net sales of $19.9 billion, up 15%. Fourth quarter GAAP diluted earnings per share from continuing operations reached $3.10, representing a 39% increase from the same period last year. The company also reported full year GAAP EPS of $11.07 and provided an outlook for the first quarter of fiscal 2027 expecting sales of approximately $5.35 billion.

    Source: SEC EDGAR

  • 8-KGEVGE Vernova Inc.

    Current report

    GE Vernova Inc. filed a current report on October 28, 2026, announcing its third-quarter 2026 financial results. The results were made available on the company's investor relations website.

    Source: SEC EDGAR

  • Press releaseUUUUEnergy Fuels Inc.

    Energy Fuels Announces Conference Call and Webcast Details for Q3-2026 Earnings

    Source: PR NewswireIndustry MNGIndustry OILSubject CCA

  • Press releaseUUUUEnergy Fuels Inc.

    Energy Fuels Announces Conference Call and Webcast Details for Q3-2026 Earnings

    Source: PR NewswireIndustry MNGIndustry OILSubject CCA

  • Press releaseOTISOtis Worldwide Corporation

    OTIS REPORTS THIRD QUARTER 2026 RESULTS

    Source: PR NewswireIndustry MACIndustry MNGSubject ERN

  • Press releaseBIIBBiogen Inc.

    Cambridge, Mass. – October 28, 2026

    Biogen Inc. reported third quarter 2026 total revenue of $2.8 billion, representing an 11% increase year-over-year. The company posted a GAAP diluted loss per share of $(0.14) and a Non-GAAP diluted EPS of $2.62. Additionally, Biogen raised the lower end of its full year 2026 Non-GAAP diluted EPS guidance range to $12.20 to $13.00.

    Source: SEC EDGAR

Press releases and filings from SEC EDGAR and PR Newswire. AI summaries can miss details: read the original before you act. Not investment advice.